Identification of BRCA mutations in breast cancer (BC) patients influences treatment and survival and may be of importance for their relatives. Testing is often restricted to women fulfilling high-risk criteria. | Current guidelines for BRCA testing of breast cancer patients are insufficient to detect all mutation carriers